Article · 13 Nov 2026
ArticlePublished 2013
Therapeutic Strategies in the Second Line Setting of Advanced or Metastatic Pancreatic Adenocarcinoma
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Pancreatic cancer is a lethal disease and its prognosis remains dismal. The modest results of existing available treatments inthe second line setting reveal the need of new therapeutic strategies. In this year’s American Society of Clinical Oncology(ASCO) Annual Meeting two remarkable trials and one retrospective analysis were presented regarding this vulnerablegroup of patients. According to the published results, docetaxel plus oxaliplatin (Abstract #4034), selumetinib plus erlotinib(Abstract #4014) and nab-paclitaxel (Abstract #e15057) have shown promising efficacy and manageable toxicity that shouldbe elucidated and confirmed by new prospective, large, randomized trials.
Subjects
Gastroenterology & HepatologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of the Pancreas.
Article · 25 Jun 2026
Comparative outcomes of Open and Laparoscopic drainage in Walled off Pancreatic Necrosis
Article · 24 Feb 2026
Xanthogranulomatous Pancreatitis Showing Overlapping
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of the Pancreas
- SubjectGastroenterology & Hepatology
- BylineArticles whose byline prints “Muhammad Wasif Saif”
- BylineArticles whose byline prints “Kostas N Syrigos”
- BylineArticles whose byline prints “Vasilis Stefanos Ramfidis”